CASE REPORT

 

Description of a concurrent thyroid haemangioma and a follicular adenoma

 

 

Liezel Coetzee^I; Wilhelmina Conradie^II; Razaan Davis^III; Rubina Razack^I

^IDivision of Anatomical Pathology, Department of Pathology, National Health Laboratory Service, Faculty of Medicine and Health Sciences, Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa
^IIDivision of General Surgery, Department of Surgery, Faculty of Medicine and Health Sciences, Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa
^IIIDivision of Radiodiagnosis, Department of Medical Imaging and Clinical Oncology, Faculty of Medicine and Health Sciences, Tygerberg Hospital and Stellenbosch University, Cape Town, South Africa

Correspondence

 

 

---

ABSTRACT

Thyroid gland vascular proliferations pose a challenge to pathologists, radiologists and surgeons. This is illustrated in the case of a 36-year-old woman who underwent a diagnostic thyroid lobectomy for a suspected follicular neoplasm according to cytology. Histological diagnosis confirmed a follicular adenoma as well as a cavernous haemangioma or venous malformation.
CONTRIBUTION: Thyroid vascular lesions are rare. Evolving nomenclature and application of the International Society for the Study of Vascular Anomalies classification are discussed. Pertinent radiological clues are highlighted to pre-empt the diagnosis and avoid potential surgical complications.

Keywords: vascular proliferations; thyroid; ISSVA classification; radiology; pathology.

---

 

 

Introduction

The spectrum of vascular proliferations in the thyroid includes reactive proliferative changes, benign to malignant tumours and a range of malformations. These lesions are considered controversial in thyroid pathology, as consistency in nomenclature and aetiopathogenesis is lacking, particularly so for benign proliferations.^1,2,3 Further contention arises when these lesions occur secondary to haemorrhage in a nodular goitre or following a fine-needle aspiration biopsy (FNAB) procedure field.^1,3

A case of a vascular lesion is presented, initially discovered by histological evaluation of a thyroid lobectomy resection specimen performed for nodular thyroid disease and confirmed by retrospective review of the ultrasound (US) images. Although traditionally regarded as a cavernous haemangioma, this report discusses the evolving nomenclature and aetiopathogenesis in the field of vascular pathology as applied to the thyroid gland. Because of their low incidence and non-specific features on US, thyroid haemangiomas are considered a challenging preoperative diagnosis.⁴ Pertinent radiological clues are highlighted to pre-empt the diagnosis and avoid potential surgical complications.

 

Ethical considerations

Ethical clearance to conduct this study was obtained from the Stellenbosch University, Health Research Ethics Committee (No. C22/11/039).

 

Patient presentation

A 36-year-old woman, whose father was known to have thyroid cancer, presented with a 3-year history of a progressively enlarging left neck mass, causing intermittent shortness of breath. Ultrasound findings showed a 43 mm × 41 mm × 27 mm solid, isoechoic homogenous nodule with a thin peripheral halo (Figure 1a) and predominantly peripheral flow (Figure 1b and c), which was aspirated and diagnosed as a Bethesda IV category: consistent with a follicular neoplasm or suspicious for a follicular neoplasm. A diagnostic left thyroid lobectomy was performed and on macroscopic inspection, a dominant nodule measuring 45 mm × 35 mm was found with a tan and haemorrhagic cut appearance. On microscopic evaluation, a follicular adenoma was present with a mixed micro- and macrofollicular growth pattern, measuring 45 mm × 35 mm (Figure 2a).

 

 

 

 

In addition, a vascular lesion measuring 5 mm × 8 mm was identified immediately superior to the follicular adenoma, comprising large cystic, thin-walled, blood-filled spaces, lined by flattened cells and separated by connective tissue (Figure 2b). Organising thrombi were evident in some of the spaces. Absence of elastic fibers on the Van Gieson's stain and positive endothelial cells with CD31 immunohistochemistry confirmed these spaces to be venous in nature. The morphological picture was in keeping with what was historically referred to as a cavernous haemangioma. A retrospective review of the US images identified a focal area of increased flow superior and adjacent to the well-defined larger isoechoic nodule (Figure 3), that correlated with the lesion identified on the histological specimen.

 

 

Management and outcome

The patient had an uneventful post-operative course, and was discharged after short term follow-up.

 

Discussion

Neoplastic vascular proliferations in the thyroid gland are rare, and malformations even more so, with just under 40 cases published to date.^{4,5,6,7,8,9,10,11,12} From the literature review, all the neoplastic vascular proliferations were called haemangioma, some qualified by a descriptor of cavernous, and fewer as capillary.^{4,5,6,7,8,9,10,13,14,15,16} The term 'haemangioma' is non-specific and, in some ways, a misnomer. It refers to a vast array of potential benign vascular anomalies that give the impression by using the suffix 'oma' that it is neoplastic in nature when this may not necessarily be the case.

To standardise terminology, the International Society for the Study of Vascular Anomalies (ISSVA) established a basic and systematic classification of vascular anomalies. The ISSVA broadly groups vascular lesions into two domains: vascular tumours with a spectrum from benign to malignant, and vascular malformations classified as non-neoplastic (Table 1). The latter is further divided according to the type of vessels involved (capillary, lymphatic, venous, arteriovenous) and their respective complexities.^13,14,17 According to this classification, cavernous haemangioma falls under the category venous malformations. With the ISSVA classification, vascular malformations are also divided into haemodynamic flow patterns, that is, no flow to low flow versus high flow. A venous malformation is typically low flow. In this case, Doppler spectral flow was not captured.

 

 

The current World Health Organization (WHO) Classification of Endocrine Tumours still uses the term haemangioma with cavernous haemangioma forming one of many other subtypes.² Although the authors do state that haemangiomas should be regarded as a non-neoplastic vascular malformation, further clarification is not provided.²

The thyroid gland, like other endocrine organs, is markedly vascular, making it prone to haemorrhage, haematoma formation with organising fibrosis and endothelial reparative injury. Excessive bleeding can give rise to secondary haemangiomas in that vascular proliferation (neovascularisation) takes place attempting to organise the haematoma, also described as pseudomalformations.⁶ Other differential diagnoses that should be considered include granulation tissue, reactive or malformative vascular polyps and papillary endothelial hyperplasia.² These regressive changes make diagnosing a vascular lesion in the thyroid gland contentious. We believe that the haemangioma described in the presented case was a primary lesion. Justification for this is that it was distinct from the follicular adenoma, was not associated with any reparative type of injury and was evident on US before the FNAB.

Preoperative diagnosis of vascular lesions in the thyroid is challenging as there are no distinctive signs on ultrasonography.⁴ A lower diagnostic awareness exists as these lesions are infrequently encountered. Some authors have suggested that thyroid haemangiomas can be correctly diagnosed preoperatively as well-circumscribed, compressible hypoechoic lesions with multiple, internal linear septations because of the presence of multiple vascular channels.^4,8 Slow flow and dilated vascular channels predispose to thrombosis and phlebolith formation, noticed by coarse calcification.⁸ These features were not identified on the greyscale US images in our case, most likely because the lesion was small. As with most cited reports, a confident diagnosis of a haemangioma or venous malformation could only be made on post-surgical pathological examination.^{4,5,6,7,8,9,10,11,12}

We conclude by emphasising using current terminology as recommended by the ISSVA to ensure reproducibility from a pathological nomenclature perspective and to correlate with appropriate radiological haemodynamic flow studies. Although it may seem inconsequential in this case, accurate terminology is important in other settings as the natural history and treatment options vary depending on the type of vascular anomaly.^15,16 In some cases, natural involution with minimal intervention is needed, compared to other lesions where possible preoperative therapeutic interventions like sclerotherapy and oral propanol can reduce surgical risk and postoperative complications. We agree with others that the term 'haemangioma' is too often used and incorrectly so, as is evident in the literature review titles.^{4,5,6,7,8,9,10,15,16}

 

Conclusion

This case illustrates a rare entity of a primary thyroid cavernous haemangioma or venous malformation incidentally and concurrently diagnosed with a dominant follicular adenoma. The controversy surrounding vascular proliferations of the thyroid gland can be resolved with increased awareness of diagnostic pitfalls in pathology and appropriate clinical pathological correlation with imaging in a multidisciplinary team. The application of the ISSVA classification for all vascular lesions is encouraged for future case reports and research to improve reproducibility in the nomenclature of vascular lesions, including that of the thyroid.

 

Acknowledgements

Competing interests

The authors declare that they have no financial or personal relationship(s) that may have inappropriately influenced them in writing this article.

Authors' contributions

L.C. and W.C. were responsible for conceptualisation. R.R. and L.C. co-wrote the original draft and contributed the pathological detail. W.C. provided the surgical input, and R.D. contributed to the imaging. All authors revised and approved the final manuscript.

Funding information

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Data availability

Data sharing is not applicable to this article.

Disclaimer

The views and opinions expressed in this article are those of the authors and are the product of professional research. It does not necessarily reflect the official policy or position of any affiliated institution, funder, agency or that of the publisher. The authors are responsible for this article's results, findings and content.

 

References

1. Papotti M, Arrondini M, Tavaglione V, Veltri A, Volante M. Diagnostic controversies in vascular proliferations of the thyroid gland. Endocr Pathol. 2008;19(3):175-183. https://doi.org/10.1007/s12022-008-9039-x        [ Links ]

2. Hyrcza MD, Calonje JE. Mesenchymal and stromal tumours. In: Tallini G, Lazar AJ, editors. WHO classification of tumours editorial board. endocrine and neuroendocrine tumours [homepage on the Internet]. 5th ed. International Agency for Research on Cancer; 2022. [cited 2024 Jan 30]. Available from: https://tumourclassification.iarc.who.int/chaptercontent/53/132        [ Links ]

3. Hovi SI, Kholová I. Vascular proliferation of the thyroid: Potential histopathological pitfalls as a consequence of fine needle aspiration. Acta Cytol. 2017;61(3):179-186. https://doi.org/10.1159/000476024        [ Links ]

4. Park SH, Kim SJ, Jung HK. Thyroid hemangiomas diagnosed on sonography. J Ultrasound Med. 2014;33(4):729-733. https://doi.org/10.7863/ultra.33.4.729        [ Links ]

5. Nejad KJ. Haemangioma of the thyroid gland. Pathology. 2012;44(January 2011):S84. https://doi.org/10.1016/S0031-3025(16)32832-X        [ Links ]

6. Gutzeit A, Stuckmann G, Tosoni I, Erdin D, Binkert CA. A cavernous hemangioma of the thyroid gland: First documentation by ultrasound of a rare pathology. J Clin Ultrasound. 2011;39(3):172-174. https://doi.org/10.1002/jcu.20738        [ Links ]

7. Kumamoto K, Sugano K, Hoshino M, Utsumi Y, Suzuki S, Takenoshita S. Cavernous hemangioma of the thyroid. Thyroid. 2005;15(10):1199-1201. https://doi.org/10.1089/thy.2005.15.1199        [ Links ]

8. Yang D-B, Lan HF, Shi PD, Wang YC, Lu M. Evaluation of thyroid hemangioma by conventional ultrasound combined with contrast-enhanced ultrasound: A case report and review of the literature. J Int Med Res. 2020;48(9):1-7. https://doi.org/10.1177/0300060520954718        [ Links ]

9. Miao J, Chen S, Li Y, Fu L, Li H. A primary cavernous hemangioma of the thyroid gland: A case report and literature review. Medicine (United States). 2017;96(49):e8651. https://doi.org/10.1097/MD.0000000000008651        [ Links ]

10. Kumar R, Gupta R, Khullar S, Dasan B, Malhotra A. Thyroid hemangioma. A case report with a review of the literature. Clin Nucl Med. 2000;25(10):769-771. https://doi.org/10.1097/00003072-200010000-00003        [ Links ]

11. Ajadi E, Dueber J, Randle RW, Lee CY. Unexpected arteriovenous malformation of the thyroid resulting in significant intraoperative blood loss. J Surg Case Rep. 2020;2020(9):1-4. https://doi.org/10.1093/jscr/rjaa277        [ Links ]

12. Černá M, Třeška V, Krčma M, Daum O, Šlauf F. Arteriovenous malformation of the thyroid gland as a very rare cause of mechanical neck syndrome: A case report. J Med Case Rep. 2015;9(1):1-6. https://doi.org/10.1186/1752-1947-9-3        [ Links ]

13. George A, Mani V, Noufal A. Update on the classification of hemangioma. J Oral Maxillofac Pathol. 2014;18(5):117-120. https://doi.org/10.4103/0973-029X.141321        [ Links ]

14. Steele L, Zbeidy S, Thomson J, Flohr C. How is the term haemangioma used in the literature? An evaluation against the revised ISSVA classification. Pediatr Dermatol. 2019;36(5):628-633. https://doi.org/10.1111/pde.13885        [ Links ]

15. Behr GG, Johnson CM. Vascular anomalies: Hemangiomas and beyond - Part 2, slow-flow lesions. Am J Roentgenol. 2013;200(2):423-436. https://doi.org/10.2214/AJR.11.7853        [ Links ]

16. Colletti G, Deganello A. Cavernous hemangioma: A term to be canceled. Eur Arch Oto-Rhino-Laryngol. 2017;274(4):2069-2070. https://doi.org/10.1007/s00405-016-4324-7        [ Links ]

17. Kunimoto K, Yamamoto Y, Jinnin M. ISSVA classification of vascular anomalies and molecular biology. Int J Mol Sci. 2022;23(4):2358. https://doi.org/10.3390/ijms23042358        [ Links ]

 

 

Correspondence:
Liezel Coetzee
lc@sun.ac.za

Received: 26 Jan. 2024
Accepted: 14 May 2024
Published: 31 July 2024